Article info
PDFLiver
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
- Correspondence to:
Dr H Yoshida
Department of Gastroenterology, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-8655, Japan; yoshida-2imh.u-tokyo.ac.jp
Citation
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
Publication history
- Accepted October 20, 2003
- First published February 11, 2004.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Gut